7Baggers
 Published on: 2025-11-16 11:45:49  newser.com Sun, 16 Nov 2025 17:45:49 GMT
 Stifel Nicolaus Remains a Buy on Pyxis Oncology (PYXS)  The Globe and Mail Fri, 14 Nov 2025 08:00:00 GMT
 jefferies keeps their buy rating on pyxis oncology (pyxs)  The Globe and Mail Fri, 14 Nov 2025 08:00:00 GMT
 Published on: 2025-11-13 12:18:01  newser.com Thu, 13 Nov 2025 18:18:01 GMT
 pyxs news today | why did pyxis oncology stock drop today?  MarketBeat Mon, 10 Nov 2025 08:00:00 GMT
 ranking pyxis oncology inc. among high performing stocks via tools  newser.com Mon, 10 Nov 2025 07:30:43 GMT
 pyxis oncology (pyxs) projected to post earnings on tuesday  MarketBeat Wed, 05 Nov 2025 17:14:58 GMT
 pyxis oncology resumed with a buy at stifel  MSN Wed, 05 Nov 2025 02:54:36 GMT
 pyxis oncology (nasdaq:pyxs) issues quarterly earnings results  MarketBeat Tue, 04 Nov 2025 14:27:29 GMT
 lifesci capital maintains pyxis oncology(pyxs.us) with buy rating  富途牛牛 Tue, 04 Nov 2025 12:32:00 GMT
 Pyxis Oncology And 2 Other Promising Penny Stocks To Watch  Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
 Pyxis Oncology Keeps Losses Steady As It Eyes Key Trial Data  Finimize Tue, 04 Nov 2025 01:16:58 GMT
 pyxis oncology keeps losses steady as it eyes key trial data  Finimize Mon, 03 Nov 2025 12:58:13 GMT
 Pyxis Oncology reports Q3 EPS (35c), consensus (34c)  TipRanks Mon, 03 Nov 2025 12:26:32 GMT
 pyxis oncology reports q3 net loss of $22 mln  MarketScreener Mon, 03 Nov 2025 12:17:51 GMT
 published on: 2025-11-03 05:42:22  newser.com Mon, 03 Nov 2025 11:42:22 GMT
 Pyxis Oncology to Participate in Upcoming Investor Conferences  Yahoo Finance Mon, 03 Nov 2025 08:00:00 GMT
 Pyxis Oncology resumed with a Buy at Stifel  TipRanks Mon, 03 Nov 2025 08:00:00 GMT
 Pyxis Oncology, Inc. SEC 10-Q Report  TradingView Mon, 03 Nov 2025 08:00:00 GMT
 William Blair Maintains Pyxis Oncology(PYXS.US) With Hold Rating  富途牛牛 Mon, 03 Nov 2025 08:00:00 GMT

Pyxis Oncology, Inc.
(NASDAQ:PYXS) 

PYXS stock logo

Pyxis Oncology, Inc., a preclinical stage biotechnology company, engages in the development of antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies to treat cancers. Its preclinical products pipeline includes PYX-201, a site-specific investigational ADC targeting onco-fetal ...

Founded: 2018
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends